Cargando…
Long-term follow-up of patients undergoing renal sympathetic denervation
OBJECTIVES: Renal denervation (RDN) proved to significantly lower blood pressure (BP) at 2–6 months in patients on and off antihypertensive drugs. Given a lack of longer-term follow-up data, our aim was to assess the safety and efficacy of RDN up to five years taking into account antihypertensive dr...
Autores principales: | Zeijen, Victor J. M., Feyz, Lida, Nannan Panday, Rajiv, Veen, Kevin, Versmissen, Jorie, Kardys, Isabella, Van Mieghem, Nicolas M., Daemen, Joost |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622524/ https://www.ncbi.nlm.nih.gov/pubmed/35851428 http://dx.doi.org/10.1007/s00392-022-02056-5 |
Ejemplares similares
-
Renal sympathetic denervation in patients with vasospastic angina
por: Feyz, Lida, et al.
Publicado: (2019) -
Association between renal sympathetic denervation and arterial stiffness: the ASORAS study
por: Zeijen, Victor J.M., et al.
Publicado: (2023) -
Effect of renal denervation on catecholamines and the
renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020) -
Atrial fibrillation reduction by renal sympathetic denervation: 12 months’ results of the AFFORD study
por: Feyz, Lida, et al.
Publicado: (2018) -
Endovascular renal sympathetic denervation to improve heart failure with reduced ejection fraction: the IMPROVE-HF-I study
por: Feyz, L., et al.
Publicado: (2021)